R. Paolini et al., Idiopathic thrombocytopenic purpura treated with steroid therapy does not prevent acute myocardial infarction: a case report, BL COAG FIB, 10(7), 1999, pp. 439-442
We report the case of a 65-year-old man affected by idiopathic thrombocytop
enic purpura, who developed an acute myocardial infarction after 2 years of
steroid therapy. Thrombocytopenia was initially recognized II years earlie
r, and became severe during the past 2 years [platelets (PLTS) 10000-30000/
mu l]. He was treated with steroids, initially to perform a surgical proced
ure (prednisone 75 mg/day), subsequently to maintain a platelet count of ab
out 50000/mu l (prednisone 12.5 mg/day). After 1 year of treatment, he bega
n to complain about exertional angina and dyspnea. His blood pressure becam
e elevated and cholesterol level raised. The exercise electrocardiogram, pr
eviously manifesting ischaemic changes, normalized after 1 month of steroid
wash-out; however, steroid therapy was reinstituted (prednisone 5 mg per d
ay). One year later, he suffered an infero-lateral non-Q-wave myocardial in
farction. It seems likely that the severe coronary atherosclerosis present
in our patient developed despite a low platelet count, under the spur of a
heavier risk factor profile. Steroid therapy could have had a role as a pre
cipitating agent of the acute event, and the opportunity of alternative tre
atments is considered. (C) 1999 Lippincott Williams & Wilkins.